Search

everythinglearnresearchcommunity

for

Search:↓

Endocrine disorders can cause various skin and hair issues.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

The document lists various dermatology topics, treatments, and diagnostic methods.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Effective treatments for scalp psoriasis include glucocorticosteroids, Vitamin D3 analogs, and combination therapies like calcipotriol and betamethasone dipropionate.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The document concludes that accurate diagnosis and understanding the type of hair disorder are crucial for treating hair loss in children.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Liposomes improve drug delivery and reduce skin irritation in dermatology.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Some alternative treatments for hair loss might work, but more research is needed.

Hair extensions can cause hair loss and scalp damage, and these problems might be more common than people realize.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

The Arabic Skindex-16 is a reliable and valid way to measure the impact of skin conditions on quality of life in Saudi patients.

Nanotechnology improves cosmetics' effectiveness and safety.

Some psychiatric drugs can cause skin problems, but serious reactions are rare.

Teledermatology is highly accurate for diagnosing inflammatory skin conditions.

Biotin supplements improved skin and hair problems in a girl with biotinidase deficiency.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Hair product allergies are common, especially to hair dyes, and hairdressers are at higher risk.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Combining microneedling with platelet-rich plasma enhances skin repair and collagen production but may not offer significant extra benefits.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

Many substances, including chemicals and metals, can cause skin reactions; careful handling and identification of allergens are crucial to prevent dermatitis.

A natural steroid in the body may protect against eye damage in glaucoma.